Literature DB >> 30771212

Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control.

Bridget G Parsons1, Jennifer L Hay2, Lisa G Aspinwall3, Kelsey Zaugg1, Angela Zhu1, Ryan H Mooney1, Stephanie Z Klein4, Douglas Grossman1,4, Sancy A Leachman5, Yelena P Wu6,7.   

Abstract

Melanoma is the deadliest form of skin cancer. Screening can aid in early disease detection, when treatment is more effective. Although there are currently no consensus guidelines regarding skin screening for pediatric populations with elevated familial risk for melanoma, at-risk children with the help of their parents and healthcare providers may implement skin self-exams. Healthcare providers may also recommend screening practices for these children. The goal of the current study was to describe current screening behaviors and provider recommendation for screening among children of melanoma survivors. Parents of children with a family history of melanoma completed a questionnaire that included items on children's screening frequency, thoroughness, and who performed the screening. Seventy-four percent of parents reported that their children (mean age = 9.0 years, SD = 4.8) had engaged in parent-assisted skin self-exams (SSEs) in the past 6 months. Only 12% of parents reported that children received SSEs once per month (the recommended frequency for adult melanoma survivors). In open-ended responses, parents reported that healthcare providers had provided recommendations around how to conduct SSEs, but most parents did not report receiving information on recommended SSE frequency. Twenty-six percent of parents (n = 18) reported that children had received a skin exam by a healthcare provider in the past 6 months. The majority of children with a family history of melanoma are reportedly engaging in skin exams despite the lack of guidelines on screening in this population. Future melanoma preventive interventions should consider providing families guidance about implementing screening with their children.

Entities:  

Keywords:  Cancer control; Children; Familyᅟ; Melanoma; Screening

Mesh:

Year:  2020        PMID: 30771212      PMCID: PMC6697232          DOI: 10.1007/s13187-019-01489-3

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  14 in total

Review 1.  Cancer in 15- to 29-year-olds by primary site.

Authors:  Archie Bleyer; Aaron Viny; Ronald Barr
Journal:  Oncologist       Date:  2006-06

2.  A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.

Authors:  Alan C Geller; Karen M Emmons; Daniel R Brooks; Catherine Powers; Zi Zhang; Howard K Koh; Timothy Heeren; Arthur J Sober; Frederick Li; Barbara A Gilchrest
Journal:  Cancer       Date:  2006-08-15       Impact factor: 6.860

3.  Melanoma risk assessment based on relatives' age at diagnosis.

Authors:  Yelena P Wu; Wendy Kohlmann; Karen Curtin; Zhe Yu; Heidi A Hanson; Mia Hashibe; Bridget G Parsons; Jathine Wong; Joshua D Schiffman; Douglas Grossman; Sancy A Leachman
Journal:  Cancer Causes Control       Date:  2017-12-14       Impact factor: 2.506

4.  Risk factors and individual probabilities of melanoma for whites.

Authors:  Eunyoung Cho; Bernard A Rosner; Diane Feskanich; Graham A Colditz
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

5.  Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.

Authors:  Lisa G Aspinwall; Jennifer M Taber; Samantha L Leaf; Wendy Kohlmann; Sancy A Leachman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

6.  Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  David C Grossman; Susan J Curry; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Alex H Krist; Martha Kubik; Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng
Journal:  JAMA       Date:  2018-03-20       Impact factor: 56.272

7.  Incidence of childhood and adolescent melanoma in the United States: 1973-2009.

Authors:  Jeannette R Wong; Jenine K Harris; Carlos Rodriguez-Galindo; Kimberly J Johnson
Journal:  Pediatrics       Date:  2013-04-15       Impact factor: 7.124

8.  CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.

Authors:  Lisa G Aspinwall; Samantha L Leaf; Erin R Dola; Wendy Kohlmann; Sancy A Leachman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

9.  Clinical and dermoscopic characterization of pediatric and adolescent melanomas: Multicenter study of 52 cases.

Authors:  Cristina Carrera; Alon Scope; Stephen W Dusza; Giuseppe Argenziano; Gianluca Nazzaro; Alice Phan; Isabelle Tromme; Pietro Rubegni; Josep Malvehy; Susana Puig; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2017-10-09       Impact factor: 11.527

10.  Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.

Authors:  Nadine A Kasparian; Richard Bränström; Yu-mei Chang; Paul Affleck; Lisa G Aspinwall; Aad Tibben; Esther Azizi; Orna Baron-Epel; Linda Battistuzzi; William Bruno; May Chan; Francisco Cuellar; Tadeusz Debniak; Dace Pjanova; Slawomir Ertmanski; Adina Figl; Melinda Gonzalez; Nicholas K Hayward; Marko Hocevar; Peter A Kanetsky; Sancy Leachman; Wilma Bergman; Olita Heisele; Jane Palmer; Barbara Peric; Susana Puig; Dirk Schadendorf; Nelleke A Gruis; Julia Newton-Bishop; Yvonne Brandberg
Journal:  Arch Dermatol       Date:  2012-10
View more
  1 in total

1.  Investigation of skin self-examination and sunscreen use in adolescents in northern Cyprus.

Authors:  Didem Mullaaziz; Aslı Kaptanoğlu; Evren Hınçal; Emel Erdal Çalıkoğlu
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.